The type-specific polysaccharide capsule is an important virulence det
erminant in group B streptococci (GBS). The previously described inver
se relationship between the buoyant density of a GBS-isolate and the c
apsular thickness was used to assess the frequencies of polysaccharide
capsular phase-shift in clinical GBS, type III strains. Shift from in
termediate density (ID) of parental strains, to high density (HD), i.e
. shift from intermediate capsule thickness to poor encapsulation, was
found to range from 1.2 x 10(-3) to 4.8 x 10(-6). Shift from ID to lo
w density (LD), i.e. shift to abundant encapsulation, ranged from 1.9
x 10(-4) to 1.1 x 10(-7). Shifts were reversible in all cases, either
directly (HD --> LD or vice versa) or through intermediate forms. Reve
rsion frequencies were in some isolates as high as 10(-1). Phase-shift
frequencies differed more than a thousand-fold between compared strai
ns. Differences in phenotypic shift between strains were validated usi
ng flow cytometry. Possible modulation of capsule expression by change
s in culture conditions was assessed. Variation of temperature, oxygen
-tension, and presence of human serum did not affect capsule expressio
n. However, growth at pH below 5.5 decreased the amount of capsule bou
nd native type III polysaccharide, probably through phenotypic modific
ation rather than genetic shift. IS861, an insertion sequence which ha
s been proposed a regulatory function on the GBS capsule expression, w
as found in multiple copies in the isolates investigated. No differenc
es in copy numberer location of IS861 between the differently encapsul
ated phenotypes were found.